The Problem No One Wants to Name
A CEO stops sleeping. A fund manager begins drinking before market close. A founder's anxiety disorder escalates into paranoia that reshapes company strategy. A private company owner's depression renders them unable to make decisions for weeks. These are not hypothetical scenarios — Harvard Health research confirms they are recurring patterns wherever concentrated authority meets human fragility.
The advisor who serves these individuals faces a collision between two imperatives. The first is the principal's right to medical privacy. The second is the fiduciary obligation owed to shareholders, limited partners, board members, or beneficiaries whose financial interests depend on that principal's capacity to function. These imperatives cannot always coexist. When they conflict, the advisor must know where the line is and what happens when it must be crossed.
This is not a clinical question. It is a structural one. The answer depends on entity type, regulatory regime, insurance contracts, governance documents, and the specific nature of the impairment. Generalities are dangerous here. Precision is required.
Public Company Executives: The SEC Framework
Public companies operate under a disclosure regime that has no interest in protecting executive privacy when that privacy conflicts with investor protection. The framework is clear in principle and murky in application.
Regulation S-K, Item 401, requires disclosure of material information about executive officers. The SEC has never defined a bright-line rule for when an executive's health condition becomes material. The standard is whether a reasonable investor would consider the information important in making an investment decision. A CEO's controlled hypertension is not material. A CEO's psychiatric hospitalization during a critical merger negotiation almost certainly is.
The materiality analysis turns on three factors. First, the severity of the condition. A manageable condition under effective treatment presents differently than an acute episode requiring inpatient care. Second, the executive's role. The more concentrated the authority, the more likely the condition is material. A CFO's substance use disorder is material in ways that a regional vice president's identical condition is not. Third, the impact on operations. A condition that does not affect the executive's performance is harder to characterize as material than one that has already caused missed board meetings, delayed filings, or erratic strategic decisions.
The board's obligation is independent of the executive's willingness to disclose. Directors have a fiduciary duty to shareholders. If the board knows that the CEO is impaired and that the impairment is affecting the company, the board cannot subordinate its disclosure obligations to the CEO's preference for privacy. This is not a close question. Boards that have attempted to conceal material executive health information have faced derivative suits, SEC enforcement actions, and personal liability.
The advisor's role in this context is to ensure the board understands the framework before a crisis arrives. The time to establish a protocol for executive health disclosure is when every executive is healthy. Once the situation is live, the conflicts of interest, the personal loyalties, and the fear of market reaction make rational analysis nearly impossible.
Private Company Owners: Governance Without Regulators
Private companies lack the SEC's disclosure mandate, but they do not lack disclosure obligations, as the Uniform Law Commission's various model acts make clear. Those obligations arise from different sources, and they are often more ambiguous.
Operating agreements, shareholder agreements, and partnership agreements frequently contain provisions that address incapacity. Some define incapacity narrowly, requiring a physician's certification. Others define it broadly, encompassing any condition that prevents the principal from performing their duties for a specified period. The advisor must know what the governing documents say. Many do not, because many have never read them with this scenario in mind.
Fiduciary duties in private companies run between and among owners. A majority owner who conceals a mental health condition that impairs their management of the business may breach the duty of loyalty owed to minority owners. A managing member whose substance use disorder leads to operational failures may breach the duty of care. These are not theoretical risks. They are the basis for litigation that occurs with regularity in closely held businesses.
The advisor serving a private company owner must distinguish between what the owner wants to keep private and what the owner has a legal right to keep private. These are not the same thing. An owner's depression, managed with medication and therapy, with no impact on business operations, is private. The same owner's depression, untreated and causing them to miss critical deadlines, ignore key client relationships, and make irrational personnel decisions, is a governance matter that other stakeholders have a right to know about.
The conversation about this distinction is one of the most difficult an advisor will ever initiate. It requires the directness described in our framework for ethical obligations when a client is in danger. Softening the message to preserve the relationship is a failure of duty.
Fund Managers: The LP Relationship
Fund managers occupy a unique position. They are fiduciaries to their limited partners. They manage other people's money under agreements that give them broad discretion. The entire relationship is predicated on the LP's confidence in the manager's judgment. When that judgment is compromised by a mental health or substance use condition, the implications are immediate and severe.
Limited partnership agreements typically contain key-person provisions. These provisions identify specific individuals whose continued involvement is a condition of the fund's operation. If a key person becomes unable to perform their duties, the LPA may require notification to limited partners, suspension of the investment period, or both. The trigger is usually defined as the key person ceasing to devote substantially all of their business time to the fund.
A fund manager in the grip of a severe depressive episode who has not been to the office in three weeks has ceased to devote substantially all of their business time to the fund. The key-person provision has been triggered. The general partner has an obligation to notify the limited partners. The fact that the manager's absence is caused by a medical condition does not suspend the contractual obligation.
The advisor working with a fund manager in this situation must understand the LPA provisions precisely. They must also understand the practical consequences of triggering a key-person clause. LP notification may lead to redemption requests, which may force asset sales at disadvantageous prices, which may compound the damage the manager's absence has already caused. These cascading consequences create enormous pressure to conceal, delay, or characterize the situation in ways that minimize its apparent severity. That pressure must be resisted. The fiduciary standard does not bend to accommodate inconvenient facts.
Key-Person Insurance: The Underwriting Problem
Key-person life and disability insurance is a standard risk management tool for businesses that depend on a single individual's contribution. The underwriting of these policies creates a disclosure obligation that intersects directly with executive mental health.
Insurance applications require disclosure of known medical conditions. An executive who conceals a diagnosed mental health condition on a key-person insurance application has committed material misrepresentation. If the policy is later needed, the insurer will investigate, the misrepresentation will be discovered, and the claim will be denied. The business that relied on that policy will have no coverage at the moment it most needs it.
The advisor's obligation here is preventive. Before the application is submitted, the advisor must ensure the executive understands that accurate disclosure is not optional. The concern that honest disclosure will result in higher premiums or exclusions is legitimate. The response is to work with specialized brokers who understand behavioral health underwriting, not to misrepresent the applicant's history.
Existing policies present a different problem. Most key-person policies contain provisions requiring notification of material changes in the insured's health. An executive who develops a substance use disorder after issuance may have an obligation to notify the insurer. Failure to do so may not void the policy — depending on jurisdiction and policy language — but it introduces uncertainty at the worst possible time. The advisor must review policy language and coordinate with insurance counsel before a claim becomes necessary.
Succession Planning: When Acceleration Is Not Optional
Every well-advised business has a succession plan. Most succession plans assume an orderly timeline. The founder will retire at sixty-five. The CEO will provide two years of transition. The fund manager will wind down the current fund and decline to raise another. Mental health crises do not follow orderly timelines.
When a principal's behavioral health condition makes their continued leadership untenable, the succession plan must be accelerated — a scenario that may also require intervention planning for the affected individual. This acceleration is operationally, legally, and emotionally complex. The parallels with cognitive decline in a wealth creator are direct. The same dynamics — identity fusion, resistance, family conflict, enablement — apply with equal force when the impairment is psychiatric rather than cognitive.
The advisor's role in accelerated succession is coordination. The board must be informed. The successor must be prepared. The principal must be managed with dignity and firmness. The legal framework — employment agreements, equity vesting, non-compete provisions, board composition — must be understood before the conversation begins.
Accelerated succession without the principal's cooperation is a governance crisis. It requires board action, legal authority, and — in many cases — the involvement of the company's outside counsel. The advisor who attempts to manage this alone will fail. The advisor who coordinates the professional team gives the business its best chance of surviving the transition intact.
Privacy Against Duty: The Advisor's Position
The advisor sits at the intersection of competing obligations. The principal is a client. The principal's privacy is protected by law, by professional ethics, and by the trust that makes the advisory relationship functional. But the advisor also owes duties to other stakeholders — shareholders, limited partners, co-owners, beneficiaries — whose interests may require disclosure of information the principal wants to conceal.
The resolution depends on the advisor's role and the governing legal framework. An attorney's obligations differ from a financial advisor's. A board member's differ from an outside consultant's. But certain principles apply broadly.
First, the advisor cannot participate in concealment that causes harm to third parties. If the advisor knows that an executive's impairment is causing material harm to the business and that stakeholders are being kept in the dark, the advisor's continued silence makes them complicit in the breach of duty owed to those stakeholders.
Second, the advisor must distinguish between the principal's health information and the principal's functional capacity. The board does not need to know the CEO's diagnosis. The board does need to know that the CEO is unable to perform their duties. The advisor can facilitate disclosure of the latter without disclosing the former. This distinction is critical and often overlooked.
Third, the advisor must document their own actions. When the situation eventually becomes known — and it always does — the advisor's contemporaneous records of what they observed, what they recommended, and what actions were taken or refused will determine whether the advisor fulfilled their professional obligations. The importance of documentation in these scenarios cannot be overstated.
Reputational Dimensions
Executive mental health disclosure carries reputational consequences for the individual, the business, and the family. Public disclosure of a CEO's psychiatric condition will move markets. Private disclosure to co-owners will reshape internal power dynamics. Even confidential disclosure to a board creates a record that may surface in litigation, regulatory proceedings, or media inquiries.
The advisor must approach this dimension with the same rigor applied to reputational crisis management in private families, drawing on the communication frameworks developed for sensitive advisory conversations. The principles are identical: control the narrative, limit the audience, prepare for escalation, and never assume confidential information will remain confidential.
For families where the executive's role and family wealth are intertwined, the stakes compound. A founder's mental health crisis is simultaneously a governance problem, a family systems disruption, and a wealth preservation emergency. When behavioral health coordination and case management are needed, specialized professionals can bridge the clinical and advisory domains. The advisory team must address all three. Addressing only one guarantees failure in the others.
Building the Framework Before the Crisis
The time to establish protocols for executive mental health disclosure is before anyone is impaired. The advisor who waits for a crisis to raise these questions will find that every conversation is contaminated by the urgency of the moment, the fear of consequences, and the principal's defensive posture.
The proactive framework includes several components. Board-level policies on executive health disclosure that define materiality thresholds and notification procedures. Key-person insurance with accurate underwriting and clear claims protocols. Succession plans that include acute acceleration scenarios. Governance documents that define incapacity with sufficient precision to be actionable. Employment agreements that address leaves of absence, interim authority, and return-to-duty standards.
The advisor who builds this framework earns the right to invoke it when the moment comes. The advisor who raises these issues for the first time during a crisis has no institutional foundation to stand on and no established trust to draw from.
This is advisory work at its most consequential. It requires the integration of legal knowledge, governance expertise, clinical awareness, and human judgment that defines the family advisory function at its highest level. The advisor who navigates this terrain protects not only the principal but every stakeholder whose financial security depends on that principal's capacity to lead.